Clozapine-induced elevated C-reactive protein and fever mimic infection

General Hospital Psychiatry

Volumn 35, Issue 6, 2013, Pages 680.e5-680.e6

  Štuhec, Matej ^a  

^a Psychiatric Hospital Ormo   (Slovenia)

Author keywords

Case report; Clozapine; Elevated C reactive protein; Mimic infection

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CLOZAPINE; CREATINE KINASE; GAMMA GLUTAMYLTRANSFERASE; LORAZEPAM; MEMANTINE; QUETIAPINE; RAMIPRIL; TROPONIN I; ZOLPIDEM;

AGED; AGITATION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BEHAVIOR DISORDER; BODY TEMPERATURE MONITORING; CASE REPORT; CONCENTRATION (PARAMETERS); CREATINE KINASE BLOOD LEVEL; DEMENTIA; DRUG DOSE TITRATION; DRUG FEVER; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEVER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; INFECTION; PROTEIN BLOOD LEVEL; PSYCHOSIS; SIDE EFFECT; TEMPERATURE MEASUREMENT; VITAL SIGN;

CASE REPORT; CLOZAPINE; ELEVATED C-REACTIVE PROTEIN; MIMIC INFECTION;

AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; C-REACTIVE PROTEIN; CLOZAPINE; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEVER; HUMANS; INFECTION; PSYCHOTIC DISORDERS;

EID: 84885716729     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2013.03.022     Document Type: Article

References (13)

1. El-Badri S., Mellsop G. Clozapine use and outcomes among patients with treatment resistant schizophrenia. Australas Psychiatry 2011, 19:410-414.
2. De Berardis D., Serroni N., Campanella D., et al. Update on the adverse effects of clozapine: focus on myocarditis. Curr Drug Saf 2012, 7:55-62.
3. Nittenson N.C., Kando J.C., Frakenburg F.R., Zanarini M.C. Fever associated with clozapine administration (letter). Am J Psychiatry 1995, 152:1102.
4. Vanderschueren S., Deeren D., Knockaert D.C., et al. Extremely elevated C-reactive protein. Eur J Intern Med 2006, 17:430-433.
5. Schumann G., Bonora R., Ceriotti F., et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 4. Reference procedure for the measurement of catalytic concentration of alanine aminotransferase. Clin Chem Lab Med 2002, 40:718-724.
6. Schumann G., Bonora R., Ceriotti F., et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. Part 2. Reference procedure for the measurement of catalytic concentration of creatine kinase. Clin Chem Lab Med 2002, 40:635-642.
7. Schumann G., Bonora R., Ceriotti F., et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. Part 6. Reference procedure for the measurement of catalytic concentration of gamma-glutamyltransferase. Clin Chem Lab Med 2002, 40:734-738.
8. Schumann G., Bonora R., Ceriotti F., et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. Part 5. Reference procedure for the measurement of catalytic concentration of aspartate aminotransferase. Clin Chem Lab Med 2002, 40:725-733.
9. Kohen I., Afzal N., Hussain S., Manu P. Increases in C-reactive protein may predict recurrence of clozapine-induced fever. Ann Pharmacother 2009, 43:143-146.
10. Røge R., Møller B.K., Andersen C.R., Correll C.U., Nielsen J. Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far?. Schizophr Res 2012, 140:204-213.
11. Tham J.C., Dickson R.A. Clozapine-induced fevers and 1-year discontinuation rate. J Clin Psychiatry 2002, 63:880-884.
12. Pui-yin Chung J., Shiu-yin Chong C., Chung K.F., et al. The incidence and characteristics of clozapine- induced fever in a local psychiatric unit in Hong Kong. Can J Psychiatry 2008, 53:857-862.
13. Ronaldson K.J., Taylor A.J., Fitzgerald P.B., et al. Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls. J Clin Psychiatry 2010, 71:976-981.